PSTX
Price:
$9.5
Market Cap:
$925.93M
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
NASDAQ
Ticker
PSTX
According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.08. This represents a change of 1.08% compared to the average of -1.28 of the last 4 quarters.
The mean historical PE Ratio of Poseida Therapeutics, Inc. over the last ten years is 12.49. The current -15.08 PE Ratio has changed -12172.51% with respect to the historical average. Over the past ten years (40 quarters), PSTX's PE Ratio was at its highest in in the December 2021 quarter at 72.44K. The PE Ratio was at its lowest in in the December 2020 quarter at -4690.67.
Average
12.49
Median
-6.27
Minimum
-199.02
Maximum
261.23
Discovering the peaks and valleys of Poseida Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 261.23
Minimum Annual Increase = -4067.76%
Minimum Annual PE Ratio = -199.02
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.46 | -58.77% |
| 2022 | -5.96 | -106.19% |
| 2021 | 96.15 | -63.19% |
| 2020 | 261.23 | -4067.76% |
| 2019 | -6.58 | -46.99% |
| 2018 | -12.42 | -59.96% |
| 2017 | -31.02 | -84.41% |
The current PE Ratio of Poseida Therapeutics, Inc. (PSTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.25
5-year avg
68.48
10-year avg
12.49
Poseida Therapeutics, Inc.’s PE Ratio is less than Gracell Biotechnologies Inc. (-1.62), less than Harpoon Therapeutics, Inc. (-1.14), less than Albireo Pharma, Inc. (-5.61), less than Verve Therapeutics, Inc. (-5.46), less than Intercept Pharmaceuticals, Inc. (5.58), greater than Crescent Biopharma, Inc. (-38.39), less than Chimerix, Inc. (-11.59), less than VectivBio Holding AG (-7.94), greater than Avid Bioservices, Inc. (-34.76), less than Icosavax, Inc. (-6.88),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.62 | $989.87M | |
| -1.14 | $865.08M | |
| -5.61 | $915.89M | |
| -5.46 | $994.04M | |
| 5.58 | $794.69M | |
| -38.39 | $180.46M | |
| -11.59 | $801.08M | |
| -7.94 | $1.06B | |
| -34.76 | $798.90M | |
| -6.88 | $769.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Poseida Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Poseida Therapeutics, Inc. (PSTX)?
What is the highest PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 3-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 5-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
How does the current PE Ratio for Poseida Therapeutics, Inc. (PSTX) compare to its historical average?